Join
Live feed
·
PRReleasevia Quantisnow
Clearmind Medicine Inc. logo

Clearmind Medicine Announces Evaluation of its Psychedelic-Based Treatment (MEAI) for Potential FDA Breakthrough Therapy Designation

ByQuantisnow·Wall Street's wire, on your screen.
CMND· Clearmind Medicine Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CMND (Clearmind Medicine Inc.) and more on Quantisnow.